International Congress Amsterdam 2015

Saturday, 26.09.2015 Sunday, 27.09.2015 Monday, 28.09.2015 Tuesday, 29.09.2015 Wednesday, 30.09.2015		Sponsored symposia: Evening Symposium organised by Novartis Pharma AG: "IgE-mediated asthma: New revelations and future insights" Evening Symposium organised by Boehringer Ingelheim International GmbH: "The challenge of treating uncontrolled asthma on Step 3 and higher: Comparing options" Industry early morning symposium organised by Novartis Pharma AG: "Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient"

Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.

The next generation of lung function tests

Symposium
Chairs: Peter Sterk (Amsterdam, Netherlands), Waldemar Tomalak (Rabka-Zdroj, Poland)
Aims: To provide an overview of the development and possibilities of breath analysis tests, the new technologies that are available (monitoring VOCs in asthma and COPD during the daily lung function routine), the roles that FeNO and exhaled breath temperature play among the other lung function tests and how these new techniques will be integrated practically into the existing technology.
Target audience: Clinicians, nurses, respiratory function technologists, scientists, and physiologists.

Download all media

Origin and development of measuring exhaled breath Stephen James Fowler (Preston, United Kingdom)
When will exhaled biomarkers influence diagnosis and follow-up of patients with respiratory disease? Ildikó Horváth (Budapest, Hungary)
Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function Niki Fens (Amsterdam, Netherlands)
Back to the future: integrating breath analysis in lung function equipment Paolo Paredi (London, United Kingdom)